School of Medicine

The Latest

21 Years Old and Experiencing Stroke, Condition On the Rise among Young Adults

One in every eight strokes at UC San Diego Health occur in an adult younger than 50.

Stem Cell Grafts and Rehabilitation Combined Boost Spinal Cord Injury Results

In animal models, UC San Diego researchers found that intensive physical therapy in tandem with implanted neural stem cells increased tissue growth, repair and functionality in spinal cord injuries more than those treatments alone.

A colorized scanning electron micrograph shows a cultured human neuron with dendrites and axons.

UC San Diego Joins National Trial to Test Drug for Treating MPOX

UC San Diego will be one of multiple sites assessing the safety and efficacy of tecovirimat as a potential treatment for human monkeypox. Marketed as TPOXX, tecovirimat is an antiviral currently approved for treatment of human smallpox in adults and children caused by the variola virus.

Popular Pharmaceutical Target in Cells May Prove Even More Useful

Researchers at UC San Diego have identified a new signaling process involving G protein-coupled receptors (GPCRs), a cellular target already exploited by hundreds of diverse drugs. The discovery opens the possibility of new therapies, including for multiple forms of cancer.

UC San Diego Launches New Human Milk Institute

Building upon a long history, the UC San Diego has launched a new Human Milk Institute to accelerate research into the biology and therapeutic potential of human milk to prevent or treat both infant and adult diseases. The new institute is believed to be the first of its kind in the United States.

Novel Study Identifies Key Molecular Players in Rheumatoid Arthritis

Using a novel systems biology approach, scientists at UC San Diego School of Medicine have further parsed the cellular players and roles involved in rheumatoid arthritis, a complex disease that affects more than one million Americans in ways that have defied development of uniform treatments.